Navigation Links
Early therapy aids eyesight

Early therapy for early outset glaucoma appears to slow the advancement of the disease. Researchers report immediate treatment of the most common form of glaucoma appears to impact the progression of vision loss.// This has very few significant signs. Doctors are able to detect it only in a detailed eye exam. In this study, doctors recruited 202 patients who had early stage glaucoma in one eye. Around half of the group was treated with medicine and laser to reduce the amount of internal pressure in the eye. The rest of the group was left untreated. Patients who later showed signs of developing the disease were offered treatment.

Six years into the study, doctors found the disease progressed more slowly in the treated patients than in the untreated patients. In the treated patients, eye pressure was lowered by about 25 percent. Many patients showed no disease progression during the study. However, researchers are concerned that as many as 20 percent of treated patients went on to develop glaucoma. The lead author of the study, Anders Heijl, M.D., Ph.D., suspects glaucoma progresses at different speeds in patients and those with an aggressive form of the disease were not helped much by treatment.

The most common form of glaucoma affects nearly 1.0 million people over age 45. While doctors find treating eye pressure may help slow the disease, they do not believe elevated eye pressure necessarily is the cause of the disease. Further research will be done to continue to understand the cause.


'"/>




Page: 1

Related medicine news :

1. Early detection of prostate cancer
2. Early detection of heart attack
3. Early puberty linked to nutrition
4. Early Clue to Down Syndrome
5. Early delivery can prevent cancer
6. Early puberty more resistance
7. Early menopause- The cause
8. Early menopause- The cause
9. Early Warning System For Breast Cancer
10. Early detection of colorectal cancer may be hindered by coloured toilet disinfectants
11. Early Detection Of Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Early therapy aids eyesight

(Date:5/12/2008)...n-compliance with California Environmental ...S, May 12 /PRNewswire-USNewswire/ -- Providence Ho...ith the planned expansion of its,Holy Cross Medica...Knew,Jr. has upheld charges that the approval pro...ceremony held today appears to be an attempt to cr...
(Date:5/12/2008)...e-FirstCall/ - Med-Emerg International Inc.,(OTCBB...uing operations,for the three months ended March ...n for the same period in 2007 (all amounts are $US...iod, earnings before,depreciation, amortization, i...a loss of ($106K) in 2007. The improvement in EBIT...
(Date:5/12/2008)...RNewswire-FirstCall/ -- (Nasdaq: WHRT, TSX:,WHT) W...ration") announced,that the Toronto Stock Exchange...viewing the eligibility for continued listing on t...ctions 709 and 710(a) of the TSX Company,Manual. T...ition and,operating results, more specifically whe...
(Date:5/12/2008).../PRNewswire/ -- Keck Graduate Institute (KGI),toda...remony will feature,the graduation of KGI,s first ...d the unveiling of KGI,s first donated artwork., ...nt in becoming the,first graduate of our new PhD p...president for academic affairs, dean of faculty an...
Breaking Medicine News(10 mins):Health News:Providence Holy Cross Medical Center Ignores Community, Environmental Concerns With Planned Expansion of Mission Hills Facility 2Health News:Med-Emerg International Inc. reports improved income from continuing operations 2Health News:Med-Emerg International Inc. reports improved income from continuing operations 3Health News:WorldHeart Notified of TSX Delisting Review 2Health News:KGI 2008 Commencement Features First PhD Graduate, Biotech Painting 2
... of teenagers may find this hard to digest, but sc...n their ‘raging hormones' and infamous// behavior,... one specific hormone-THP. The experiments, by Sh...University of New York, offer the first physiologi...
... More than six months has passed since a research ...a against bird flu//. But there seem to be no take...er the avian influenza scare last year. The High ...ADL) here, which developed the vaccine in July 200...
...disease occurs more often than we think, but it is...ally when caught early//. Children and adolescents...ase that seems to suddenly strike young adults oft...disease develops silently and all too often manife...
...dults who devote more time to physical activity ha...e in the next 15 years, according to new research/...that physical activity is actually causally relate...ead author David Jacobs, Jr., Ph.D. Jacobs, an ep...
Other Medicine News:Health News:Mothers of Rebellious Teens- Blame It on THP 2Health News:No Takers for India's First Bird Flu Vaccine 2Health News:Kidney Disease In Children: Common but Treatable 2Health News:Physical Activity Reduces Hypertension Risk in Young Adults 2
(Date:5/12/2008)...of Phase 1 Clinical Data of MDX-1100 at Digestive ..., PRINCETON, N.J., May 12 /PRNewswire-FirstCall/ ...that it has initiated the Phase 2 clinical,develop... antibody that,targets CXCL10 (also known as IP-10...itis (RA). MDX-1100 could potentially treat UC and...
(Date:5/9/2008)...Thailand, May 9 /PRNewswire-USNewswire/ -- An emer...he Protection of Animals (WSPA),is on stand-by in ...k,Myanmar to assess and then relieve the suffering...nd on for food and their livelihoods., WSPA is ...ure,Organization of the United Nations (FAO) while...
(Date:5/9/2008)..., May 9 /- Ardea Bioscience... discovery and development of,small- molecule ther...ammatory diseases, including gout, today announced...President, Finance and Operations and Chief,Financ... from our board of,directors shortly thereafter. T...
(Date:5/8/2008)...y 8 /- Globus Medical, Inc., the larg...the world and a recognized,leader in motion preser...of,enrollment in its SECURE(R)-C Cervical Artifici...ned to mimic the normal motion of the spine in,ord...ternative to fusion in,the treatment of symptomati...
Breaking Medicine Technology:Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis 2Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis 3Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis 4Animals That Cyclone Survivors Depend on Need Help Now 2Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 2Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 3Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 4Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 6Globus Medical Completes Enrollment Of SECURE(R)-C Cervical Artificial Disc Clinical Trial 2High Meat Consumption Linked to Heightened Cancer Risk 8025 1High Meat Consumption Linked to Heightened Cancer Risk 8025 2High Meat Consumption Linked to Heightened Cancer Risk 8025 3High Meat Consumption Linked to Heightened Cancer Risk 8025 4Panomics Inc 3A Recipient of the Frost 26 Sullivan 2007 United States Drug Discovery Technologies Entrepreneurial Company of the Year Award 8020 1Panomics Inc 3A Recipient of the Frost 26 Sullivan 2007 United States Drug Discovery Technologies Entrepreneurial Company of the Year Award 8020 2Panomics Inc 3A Recipient of the Frost 26 Sullivan 2007 United States Drug Discovery Technologies Entrepreneurial Company of the Year Award 8020 3UT Southwestern 3A Patients with mild Cushing syndrome may benefit from adrenalectomy 8017 1UT Southwestern 3A Patients with mild Cushing syndrome may benefit from adrenalectomy 8017 2UT Southwestern 3A Patients with mild Cushing syndrome may benefit from adrenalectomy 8017 3News from the American Heart Association 1035 1News from the American Heart Association 1035 2News from the American Heart Association 1035 3News from the American Heart Association 1035 4News from the American Heart Association 1035 5
...AM, Mass.--(BUSINESS WIRE)--Mar 27, 2007 - Interle...t the University of,California San Diego today rep... meeting that associations between coronary artery...PL) and Lp(a),levels appear to be dependent on pro... genes., In a presentation titled "The Influence o...
...ETON, N.J.--(BUSINESS WIRE)--Mar 29, 2007 - Cytoge...coming presentation,of preclinical data at the 200...ancer Research (AACR) taking place in Los Angeles,...are based on,preclinical studies that validate nov...bodied in the Company,s proprietary,Abtides(TM) (A...
Other Medicine Technology:ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 2ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 3Preclinical Data on Cytogen's Technology to be Reported at the AACR,Annual Meeting 2Preclinical Data on Cytogen's Technology to be Reported at the AACR,Annual Meeting 3Preclinical Data on Cytogen's Technology to be Reported at the AACR,Annual Meeting 4
Single piece Anterior Chamber PMMA lens, AC depth: 4.9.
... Bausch & Lomb PMMA Anterior Chamber Intraocular L...hakia in patients 60 years of age or older where a...acapsular cataract extraction; or primary extracap...ral reason that the anterior chamber lens would be...
1% Sodium Hyaluronate, 10mg/mL, sterile opthalmic injection
...isc is the right viscoelastic agent for the surgeo...extracap technique. Amvisc possesses sufficient vi...ens removal. Amvisc is highly cohesive so that com... quickly accomplished. Amvisc is priced to compete...
Medicine Products: